A Phase 2a Multi-Center Study of 18F-FDG PET Safety and Tolerability of AZD0530 in Mild Alzheimer's Disease
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this research study is to determine whether AZD0530 is safe and effective in slowing decline in brain metabolism, memory and daily function in people with Alzheimer?s disease (AD).
Description
The purpose of this study is to test whether an oral experimental drug, AZD0530, will slow progression in mild-stage Alzheimer's disease.
Details
| Condition | Alzheimer's disease |
|---|---|
| Age | 55years - 85years |
| Clinical Study Identifier | TX4969 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.